1. HBW Insight
  2. >>Ingredients & Safety

EU’s SCCS Reissues Guidance On Cosmetic Ingredient Testing With Updated Non-Animal Method Perspectives

 
• By Ryan Nelson

The Scientific Committee on Consumer Safety’s guidance offers perspective on new approach methodologies that can be used to substantiate cosmetic ingredient safety, as well as areas where alternative strategies continue to be insufficient. The document also includes updated criteria for multi-constituent natural ingredients at a time of increasing industry use.

EU Brussels

Stakeholders preparing data submissions to inform the Scientific Committee on Consumer Safety’s evaluation of cosmetic ingredients, as well as companies building Product Information Files in compliance with European cosmetics regulations, should take note of SCCS’s latest guidance.

Published Nov. 7, “SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation” is the 10th edition of the document.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Review Suggests Advantage Of Bayer’s Iberogast Advance For Digestive Disorders

 
• By David Ridley

Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.

Allergy Ingredient Itch Warning, ACNU Final Rule Scratch Extent Of FDA Authority For Label Changes

 
• By Malcolm Spicer

Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.

‘We Must Have The Truth’ – Calls For UWWTD Review Intensify As Evidence Looks ‘Shaky’

 
• By David Ridley

The evidence underpinning the “polluter pays” principle of the revised Urban Wastewater Treatment Directive - which calls on Europe's pharmaceutical industry to cough up at least 80% of the cost of updating wastewater treatment facilities - is looking increasingly shaky, according to a new report.

Supplementation Unlikely To Help With Hereditary Hair Loss, Says German Agency

 
• By David Ridley

Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”

More from HBW Insight

CRN Foundation Nurtures Charitable Clinics Network With Support

 
• By Malcolm Spicer

CRN Foundation selects National Association of Free and Charitable Clinics for Access Initiative support for increasing access to high-quality dietary supplements and essential nutrition for underserved populations.

Animal Studies Would Not Provide ‘Meaningful Insights’ Into UV Filter Safety - Study

 
• By Lauren Nardella

A new study on the safety of sunscreen filters relies on an alternative assessment methodology and concludes that six sunscreen UV filters are unlikely to be carcinogenic.

AESGP Annual Meeting: Wastewater Directive Impact Assessment ‘Fundamentally Flawed’

 
• By David Ridley

AESGP president Jonathan Workman opens the 61st Annual Meeting with calls for industry unity in the face of the problematic revised EU Urban Wastewater Treatment Directive.